Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler Jr VG, Bayer AS, et al. Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century. JAMA. 2010;169(5):463–73. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A Systematic Review of Population-Based Studies of Infective Endocarditis. Chest. 2007;132(3):1025–35. Prada G, Ferro S. Endocarditis Infecciosa. In: Chalem F Medicina Interna Fundación Instituto de Reumatología e Inmunología. 1997. p. 1337–45. Echeverría R, Rozo J, Jaramillo C, Rodríguez C. Características epidemiológicas de la endocarditis infecciosa en la Fundación Clínica A. Shaio entre 1994-2001. Rev Col Cardiol. 2002;10:59–63. Sénior JM, Lara F, Restrepo Á. Endocarditis infecciosa: descripción clínico-epidemiológica. Acta Med Colomb. 1995;20(4):169–75. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: Changing epidemiology and predictors of 6-month mortality: A prospective cohort study. Eur Heart J. 2007;28(2):196–203. Cantrell M, Yoshikawa T. Infective endocarditis in the aging patient. Gerontology. 1984;30(5):316–26. Durante-Mangoni E, Bradley SF, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current Features of Infective Endocarditis in Elderly Patients. Arch Intern Med. 2008;168(19):2095–103. Castillo FJ, Anguita M, Castillo JC, Ruiz M, Mesa D, Suárez de Lezo J. Changes in Clinical Profile, Epidemiology and Prognosis of Left-sided Native-valve Infective Endocarditis Without Predisposing Heart Conditions. Rev Esp Cardiol (Engl Ed). 2015;68(5):445–8. Lerner P, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med. 1966;274(4):199–2016. Welton D, Young J, Gentry W, Raizner A, Alexander J, Chahine R, et al. Recurrent infective endocarditis: analysis of predisposing factors and clinical features. Am J Med. 1979;66(6):932–8. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155(15):1641–8 Tuazon C, Sheagren J. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974;129(6):725–7. Lockhart P, Brennan M, Thornhill M, Michalowicz B, Noll J, Bahrani-Mougeot FSH. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140(10):1238–44. Chen S, Liu C, Chao T, Wang K. Dental Scaling and Risk Reduction in Infective Endocarditis : A Nationwide Population-Based Case-Control Study. Can J Cardiol. 2013;29(4):429–33. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation. 2007;116(15):1736–54. Gould F, Elliot T, Foweraker J, Perry J, Roberts G, Sandoe J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2006;57(6):1035–42. Griffin M, Wilson W, Edwards W, O’Fallon W, Kurland L. Infective endocarditis. JAMA. 1985;254(9):1199–202. McKinsey D, Ratts T, Bisno A. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82(4):681–8. Cherubin C, Neu H. Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med. 1971;51(1):83–9. Michel P, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Hear J. 1995;15(B):2–6. Gersony W, Hayes C, Driscoll D, Keane J. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2). Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). G Ital Cardiol. 2016;17(4):277–319. Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: An increasing clinical challenge. Eur Heart J. 2007;28(19):2307–12. Robinson D, Fowler V, Sexton D. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis. 1997;30(4):521. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis. 2005;41(3):406–9. Tornos M, Permanyer-Miralda G, Olona M. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med. 1992;117(7):567. Martin-Dávila P, Fortún J, Navas E, Cobo J, Jiménez-Mena M, Moya JL, et al. Nosocomial endocarditis in a tertiary hospital: An increasing trend in native valve cases. Chest. 2005;128(2):772–9. Finkelstein R, Sobel J, Nagler A. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J Med. 1984;15(3):193. Nahass R, Weinstein M, Bartels J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and-positive patients. J Infect Dis. 1990;162(4):967. Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;369(8):785. Mansur A, Grinberg M, da Luz P, Bellotti G. The complications of infective endocarditis. A reappraisal in the 1980s. Complicat Infect endocarditis. 1992;152(12):2428. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;294(24):3012–21. Sexton D, Spelman D. Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Cardiol Clin. 2003;21(2):273–82. Roth G, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs R. Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014. JAMA. 2017;317(19):1976. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: Results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53–60. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality. J Am Med Assoc. 2003;289(15):1933–40. Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, Almirante B, et al. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis. JAMA. 2007;297(12):1354–61. Hase R, Otsuka Y, Yoshida K, Hosokawa N. Profile of infective endocarditis at a tertiary-care hospital in Japan over a 14-year period: Characteristics, outcome and predictors for in-hospital mortality. Int J Infect Dis [Internet]. 2015;33:e62–6. Available from: http://dx.doi.org/10.1016/j.ijid.2015.01.003 Şimşek-Yavuz S, Şensoy A, Kaşikçioğlu H, Çeken S, Deniz D, Yavuz A, et al. Infective endocarditis in Turkey: Aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis. 2015;30:e106–14. Sevilla T, López J, Gómez I, Vilacosta I, Sarriá C, García-Granja PE, et al. Evolution of Prognosis in Left-Sided Infective Endocarditis: A Propensity Score Analysis of 2 Decades. J Am Coll Cardiol [Internet]. 2017;69(1):111–2. Available from: http://myaccess.library.utoronto.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=120336392&site=ehost-live Gelvez-Acebal J, Almendro-Delia M, Ruiz J, De Alarc??n A, Mart??nez-Marcos FJ, Reguera JM, et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: A multicenter cohort study. Mayo Clin Proc [Internet]. 2014;89(10):1397–405. Available from: http://dx.doi.org/10.1016/j.mayocp.2014.06.021 Madrid CA, Jaramillo AN, Roncancio G, Gonzáles JM, Franco L, Rendón JC, et al. Epidemiología de la endocarditis infecciosa en pacientes adultos atendidos en un centro cardiovascular de Colombia, experiencia de 10 años. Rev Esp Cardiol. 2014;67(1):914. Noreña IE. Caracterización clínica, microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundación Cardioinfantil 2002-2012. 2014. Camacho J, Umaña JP, Sandoval NF, Carreño M. Factores asociados a mortalidad en pacientes con endocarditis infecciosa sometidos a cirugía cardíaca. Resúmenes xxv congreso colombiano de cardiología y cirugía cardiovascular, Medellin-Colombia; 2014 Franco Sierra S, Eusse Caro A, Atehortua Trujillo M, Vélez A, Castro H, Vallejo C, et al. Endocarditis infecciosa: Análisis de resultados del manejo quirúrgico temprano. Resúmenes xxiv congreso colombiano de cardiología y cirugía cardiovascular, Cali-Colombia; 2012. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142(1):75–80. Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore) [Internet]. 2015;94(43):e1816. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84946567058&partnerID=tZOtx3y1 Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect. 2012;18(12). Thuny F, Disalvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, et al. Risk of embolism and death in infective endocarditis: Prognostic value of echocardiography-A prospective multicenter study. Circulation. 2005;112(1):69–75. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Vol. 36, European Heart Journal. 2015. 3075–3123 p Anantha Narayanan M, Mahfood Haddad T, Kalil AC, Kanmanthareddy A, Suri RM, Mansour G, et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart [Internet]. 2016;102(12):950–7. Available from: http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2015-308589 Chu VH, Cabell CH, Benjamin DK, Kuniholm EF, Fowler VG, Engemann J, et al. Early Predictors of In-Hospital Death in Infective Endocarditis. Circulation. 2004;109(14):1745–9. Daniel W, Mügge A, Martin R, Lindert O, Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324(12):795–800. Cosmi JE, Tunick PA, Kronzon I. Mortality in patients with paravalvular abscess diagnosed by transesophageal echocardiography. J Am Soc Echocardiogr. 2004;17(7):766–8. Medina M, Camacho J, Castañeda X, Carreño M. Factores asociados a mortalidad y complicaciones en endocarditis infecciosa de válvula protésica en institución hospitalaria de Colombia. Universidad del Rosario; 2015. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet [Internet]. 2016;387(10021):882–93. Available from: http://dx.doi.org/10.1016/S0140-6736(15)00067-7 McDonald JR. Acute infective endocarditis. Infect Dis Clin North Am. 2009;23(3):643–64. Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman-Igra Y. Hospital-acquired infective endocarditis: Should the definition be broadened? Clin Infect Dis. 2004;38(6):843–50. Piper C, Korfer R, Hosrtkotte D. Valve disease: prosthetic valve endocarditis. Heart. 2001;85(5):590–3. Chastre J, Trouillet J. Early infective endocarditis on prosthetic valves. Eur Hear J. 1995;(16 Suppl B):32–8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9. Ivan A, Nore E, Mar F, Beltran J. Caracterización clínica, microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundación Cardioinfantil 2002-2012 Caracterización clínica, microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundac. 2012;1–36. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017 Jan;69(3):325–44. Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. Valve surgery in active infective endocarditis: A simple score to predict in-hospital prognosis. Int J Cardiol [Internet]. 2014;175(1):133–7. Available from: http://dx.doi.org/10.1016/j.ijcard.2014.04.266 Chee Q-Z, Tan Y-QB, Ngiam JN, Win MTM, Shen X, Choo J-NJ, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: An 11-year study. Int J Cardiol [Internet]. 2015;191:273–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0167527315009705 Park LP, Chu VH, Peterson G, Skoutelis A, Lejko-Zupa T, Bouza E, et al. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc. 2016;5(4):1–14. Lee SJ, Jeon D, Cho WH, Kim YS. The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. J Korean Med Sci. 2014;29(12):1646–50. Monteiro TS, Correia MG, Golebiovski WF, Barbosa GIF, Weksler C, Lamas CC. Asymptomatic and symptomatic embolic events in infective endocarditis: associated factors and clinical impact. Brazilian J Infect Dis [Internet]. 2017;21(3):240–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1413867017301587 Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, et al. Neurological complications of infective endocarditis: New breakthroughs in diagnosis and management. Med Mal Infect [Internet]. 2013;43(11–12):443–50. Available from: http://dx.doi.org/10.1016/j.medmal.2013.09.010 Diab M, Guenther A, Sponholz C, Lehmann T, Faerber G, Matz A, et al. Pre-operative stroke and neurological disability do not independently affect short-and long-term mortality in infective endocarditis patients. Clin Res Cardiol. 2016 Oct;105(10):847–57. Ilhao Moreira R, Coutinho Cruz M, Moura Branco L, Galrinho A, Coutinho Miranda L, Fragata J, et al. Infective endocarditis: Surgical management and prognostic predictors. Rev Port Cardiol. 2018 May;37(5):387–94. Cecchi E, Ciccone G, Chirillo F, Imazio M, Cecconi M, Del Ponte S, et al. Mortality and timing of surgery in the left-sided infective endocarditis: an Italian multicentre study. Interact Cardiovasc Thorac Surg. 2018 Apr;26(4):602–9. Kang D-H, Kim Y-J, Kim S-H, Sun BJ, Kim D-H, Yun S-C, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012 Jun;366(26):2466–73. Jia L, Wang Z, Fu Q, Bu H, Wei M. Could Early Surgery Get Beneficial in Adult Patients with Active Native Infective Endocarditis? A Meta-Analysis. Biomed Res Int. 2017;2017:3459468. Olmos C, Vilacosta I, Habib G, Maroto L, Fernandez C, Lopez J, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017 Sep;103(18):1435–42. Gatti G, Benussi B, Gripshi F, Della Mattia A, Proclemer A, Cannata A, et al. A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system. Infection. 2017 Aug;45(4):413–23. Varela Barca L, Navas Elorza E, Fernendez-Hidalgo N, Moya Mur JL, Muriel Garcia A, Fernandez-Felix BM, et al. Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis. Infection. 2019 Jun Díez-Villanueva P, Muñoz P, Marín M, Bermejo J, de Alarcón González A, Fariñas MC, et al. Infective endocarditis: Absence of microbiological diagnosis is an independent predictor of inhospital mortality. Int J Cardiol [Internet]. 2016;220:162–5. Available from: http://dx.doi.org/10.1016/j.ijcard.2016.06.129 van den Brink F, Hasenaar J, Winia V, Klomp M, Van Vlies B, Nicastia D, et al. Prognostic factors in infective endocarditis in general hospitals in the Netherlands. Netherlands Hear J [Internet]. 2016; Available from: http://link.springer.com/10.1007/s12471-016-0846-2 Abdallah L, Remadi JP, Habib G, Salaun E, Casalta JP, Tribouilloy C. Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis. Arch Cardiovasc Dis [Internet]. 2016;109(4):260–7. Available from: http://dx.doi.org/10.1016/j.acvd.2015.11.012 Asgeirsson H, Thalme A, Kristjansson M, Weiland O. Incidence and outcome of Staphylococcus aureus endocarditis-a 10-year single-centre northern European experience. Clin Microbiol Infect [Internet]. 2015;21(8):772–8. Available from: http://dx.doi.org/10.1016/j.cmi.2015.04.014 Lauridsen TK, Park L, Tong SYC, Selton-Suty C, Peterson G, Cecchi E, et al. Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study. Circ Cardiovasc Imaging. 2015 Jul;8(7):e003397. Zencir C, Akpek M, Senol S, Selvi M, Onay S, Cetin M, et al. Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis. Kaohsiung J Med Sci [Internet]. 2015;31(12):632–8. Available from: http://dx.doi.org/10.1016/j.kjms.2015.10.004 Guray Y, Ipek EG, Guray U, Demirkan B, Kafes H, Asarcikli LD, et al. Red cell distribution width predicts mortality in infective endocarditis. Arch Cardiovasc Dis [Internet]. 2014;107(5):299–307. Available from: http://dx.doi.org/10.1016/j.acvd.2014.04.008 Wang TKM, Oh T, Voss J, Pemberton J. Characteristics and outcomes for right heart endocarditis: six-year cohort study. Heart Lung Circ. 2014 Jul;23(7):625–7. Chaudry MS, Carlson N, Gislason GH, Kamper A-L, Rix M, Fowler VGJ, et al. Risk of Infective Endocarditis in Patients with End Stage Renal Disease. Clin J Am Soc Nephrol. 2017 Nov;12(11):1814–22. Ramos-Martinez A, Roque F, Farinas MC, Munoz P, Verde E, Cuerpo GP, et al. Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry. Int J Cardiol. 2017 Aug;241:295–301. Nadji G, Rusinaru D, Remadi J-P, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009 Jul;11(7):668–75. CDC, NHSN. CDC / NHSN Surveillance Definitions for Specific Types of Infections. Surveill Defin. 2014;2015(January):1–24. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Clasification and Stratification [Internet]. Vol. 39, American Journal of Kidney Diseases. 2002. 1–266 p. Available from: www.kdoqi.org Guía de práctica clínica ( GPC ) basada en la evidencia científica para la atención de la infección por VIH / Sida en adolescentes ( con 13 años de edad o más ) y adultos . 2014. Guide P, Copd TO. Global Initiative for Chronic Obstructive Lung A Guide for Health Care Professionals Global Initiative for Chronic Obstructive Disease. Glob Initiat chronic Obstr lung Dis. 2010;22(4):1–30. The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA. 2016. 256 p. Centers for Diasease Control and Prevention. CDC. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). Natl Cent Emerg Zoonotic Infect Dis [Internet]. 2015;(November):24. Available from: https://www.osha.gov/SLTC/ebola/control_prevention.html Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11(2):202–19. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear J – Cardiovasc Imaging [Internet]. 2016;17(12):1321–60. Available from: https://academic.oup.com/ehjcimaging/article-lookup/doi/10.1093/ehjci/jew082 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129-2200m. Naranjo MV. Hallazgos radiográficos del edema agudo de pulmón. 2014;(609):123–7. Makris K, Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev [Internet]. 2016;37(2):85–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28303073%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5198510 Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am [Internet]. 2017;101(3):587–606. Available from: http://dx.doi.org/10.1016/j.mcna.2016.12.011 Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017 Apr;317(16):1652–60. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. Damasco P V, Ramos JN, Correal JCD, Potsch M V, Vieira V V, Camello TCF, et al. Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals. Infection. 2014 Oct;42(5):835–42. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VGJ, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar;169(5):463–73. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol. 1998 Feb;49(2):96–101. Le V, Gill S. Serious complications after infective endocarditis. Dan Med Bull. 2010 Oct;57(10):A4192. Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000 Nov;15(11):1782–7. Gagneux-Brunon A, Pouvaret A, Maillard N, Berthelot P, Lutz MF, Cazorla C, et al. Acute kidney injury in infective endocarditis: A retrospective analysis. Med Mal Infect. 2019 Apr Lopez J, Sevilla T, Vilacosta I, Garcia H, Sarria C, Pozo E, et al. Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients. Rev Esp Cardiol (Engl Ed). 2013 May;66(5):384–90. Tavazzi L, Senni M, Metra M, Gorini M, Cacciatore G, Chinaglia A, et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail. 2013 May;6(3):473–81. Choi KH, Lee GY, Choi J-O, Jeon E-S, Lee H-Y, Cho H-J, et al. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction. Heart. 2018 Mar;104(6):525–32. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007 Feb;44(3):364–72. Nagy M, Alkady H, Abo Senna W, Abdelhay S. Predictors of surgical outcome in isolated prosthetic mitral valve endocarditis. Asian Cardiovasc Thorac Ann. 2018 Sep;26(7):517–23. Grabowski M, Hryniewiecki T, Janas J, Stepinska J. Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol. 2011 Jun;258(6):1133–9. Lee SJ, Jeon D, Cho WH, Kim YS. The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. J Korean Med Sci. 2014 Dec;29(12):1646–50. Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al. Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis. 2014 Apr;14:230. Hodges KE, Hussain ST, Stewart WJ, Pettersson GB. Surgical management of infective endocarditis complicated by ischemic stroke. J Card Surg. 2017 Jan;32(1):9–13. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995 Dec;110(6):1745–55. Hubert S, Thuny F, Resseguier N, Giorgi R, Tribouilloy C, Le Dolley Y, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013 Oct;62(15):1384–92. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta J-P, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011 Aug;32(16):2027–33. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011 Nov;306(20):2239–47. Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336–45. Kang D-H. Timing of surgery in infective endocarditis. Heart. 2015 Nov;101(22):1786–91. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013 Sep;173(16):1495–504. Mistiaen WP. What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review. Scand Cardiovasc J. 2018 Apr;52(2):58–68. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Hunt JM, Copland J, McDonald CF, Barter CE, Rochford PD, Pierce RJ. Cardiopulmonary response to oxygen therapy in hypoxaemic chronic airflow obstruction. Thorax. 1989 Nov;44(11):930–6 Betancourt-Peña J, Tonguino-Rosero S. Impacto de la oxigenoterapia domiciliaria en la capacidad funcional de pacientes con enfermedad pulmonar obstructiva crónica. Rehabilitacion 2016;50:13-8 Stuart C, Bishop M, Clrak TJ, Cotes JE, Flenley DC, Howard P, Oldham D. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet Lond Engl. 1981 Mar 28;1(8222):681–6 Stein DA, Bradley BL, Miller WC. Mechanisms of Oxygen Effects on Exercise in Patients with Chronic Obstructive Pulmonary Disease. Chest. 1982 Jan 1;81(1):6–10 Kvale P, Conway W, Bower C, Zych C, Mcburney A, Baird D. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980 Sep;93(3):391–8 Sivakumaran P, Garrett JE. The prescription of domicilary long-term oxygen therapy in Auckland. N Z Med J. 1996 Nov 22;109(1034):439–42. Bagheri Nejad S, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ. 2011 Oct 1;89(10):757–65 Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014 Aug;7(4):339–44 Sydnor ERM, Perl TM. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clin Microbiol Rev. 2011 Jan;24(1):141–73 Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991 Mar 23;302(6778):709–11 Eaton TE, Grey C, Garrett JE. An evaluation of short-term oxygen therapy: the prescription of oxygen to patients with chronic lung disease hypoxic at discharge from hospital. Respir Med. 2001 Jul;95(7):582–7 Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet Lond Engl. 2010 Sep 4;376(9743):784–93 Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol Stockh Swed. 2012 Nov;51(8):996–1008 Heffner JE. The Story of Oxygen. Respir Care. 2013 Jan 1;58(1):18–31 Development WHOD of C and AH and, Technologies WHOD of EH. Informal consultation on clinical use of oxygen : meeting report, 2-3 October 2003. 2004 [cited 2018 May 29]; Available from: http://apps.who.int/iris/handle/10665/69706 Suntharalingam J, Hippolyte S, Knowles V, Freeman D, Patel I, Hardinge M. When should I be considering home oxygen for my patients? NPJ Prim Care Respir Med. 2016 Jan 7;26:15074 Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015 Jun;70 Suppl 1:i1-43 Ringbaek TJ. Continuous oxygen therapy for hypoxic pulmonary disease: guidelines, compliance and effects. Treat Respir Med. 2005;4(6):397–408 Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996 Nov;9(11):2335–9 Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983 Oct;143(10):1941–7 Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997 Aug;52(8):674–9 Gulbas G, Gunen H, In E, Kilic T. Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment. Int J Clin Pract. 2012 Feb;66(2):152–7 Spier S, Rivlin J, Hughes D, Levison H. The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis. 1984 May;129(5):712–8. 24. Smith PE, Edwards RH, Calverley PM. Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy. Thorax. 1989 Dec;44(12):997–1001 Broström A, Hübbert L, Jakobsson P, Johansson P, Fridlund B, Dahlström U. Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. J Cardiovasc Nurs. 2005;20(6):385–96 Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol. 1996 May;27(6):1486–90 González-Moro JMR, Navarrete BA, Michavila IA, Lobato SD. Oxigenoterapia continua domiciliaria. Monogr Arch Bronconeumol [Internet]. 2016 Jan 15 [cited 2018 May 29];2(5). Available from:http://separcontenidos.es/revista/index.php/revista/article/view/140 Gallagher JL, McKernan G, Slater L, DeRamon A. P44 How Long is short term Oxygen Therapy? Home Oxygen Prescriptions Post Hospitalisation. Thorax. 2012 Dec 1;67(Suppl 2):A82–A82 Arciniegas W, Bolívar F, Cano DJ. Evaluación de costos de un programa de oxigenoterapia domiciliaria. Rev Salud UIS [Internet]. 2010 [cited 2018 May 29];42(1). Available from: http://revistas.uis.edu.co/index.php/revistasaluduis/article/view/789 Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, et al. Costs of Chronic Obstructive Pulmonary Disease in Spain: Estimation From a Population-Based Study. Arch Bronconeumol Engl Ed. 2004 Feb 1;40(2):72–9 Casas F, Carlos J, Schiavi E, Mazzei JA, López AM, Rhodius E, et al. Recomendaciones para la prevención, diagnóstico y tratamiento de LA EPOC en la Argentina. Med B Aires. 2012 Aug;72(4):1–33 Warner JL, Zhang P, Liu J, Alterovitz G. Classification of hospital acquired complications using temporal clinical information from a large electronic health record. J Biomed Inform. 2016 Feb;59:209–17 Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep Wash DC 1974. 2007 Apr;122(2):160–6 Fuller RL, McCullough EC, Bao MZ, Averill RF. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financ Rev. 2009;30(4):17–32. 35. Bohlouli B, Tonelli M, Jackson T, Hemmelgam B, Klarenbach S. Risk of Hospital-Acquired Complications in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol CJASN. 2016 Jun 6;11(6):956–63 Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet Lond Engl. 2011 Jan 15;377(9761):228–41 Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017 May 1;7(5):478–82 Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309–32 Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009 Dec 2;302(21):2323–9 Nicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol J Int Union Angiol. 2013 Apr;32(2):111–260 Assareh H, Chen J, Ou L, Hillman K, Flabouris A. Incidences and variations of hospital acquired venous thromboembolism in Australian hospitals: a population-based study. BMC Health Serv Res. 2016 Sep 22;16(1):511 Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015 Aug;12(8):464–74 Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 Mar 10;352(10):969–77 HealthGrades patient safety study shows increase in hospital incidents, gaps among state, hospitals [Internet]. EurekAlert! [cited 2018 May 29]. Available from: http://www.eurekalert.org/pub_releases/2006-04/h-hps032806.php Dennis RJ, Acevedo JR, Restrepo HF, Hernández JI, Rivas E, Sabogal JE. Is current prophylaxis against venous thromboembolism (VTE) appropriate in medical patients?: Evaluation of Colombian outcomes in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). Acta Medica Colomb. 2009 Mar;34(1):11–6 Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006 Jan;1(1):13–20. Kaplan RC, Heckbert SR, Koepsell TD, Furberg CD, Polak JF, Schoen RE, et al. Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators. J Am Geriatr Soc. 2001 Feb;49(2):126–33. Herzig SJ, Rothberg MB, Feinbloom DB, Howell MD, Ho KKL, Ngo LH, et al. Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients. J Gen Intern Med. 2013 May;28(5):683–90 Valle B, Díaz JA, López JJ, Calderón CM. Evaluación de la prescripción profiláctica de omeprazol y ranitidina mediante la identificación de factores de riesgo de sangrado gastrointestinal. Rev Colomb Cienc Quím-Farm. 2017 Jan 1;46(1):36–47 Killen J, Ellis H. Assisted discharge for patients with exacerbations of chronic obstructive pulmonary disease: safe and effective. Thorax. 2000 Nov 1;55(11):885–885 Instituto de Cardiologia, Fundacion Cardioinfantil Colombia [Internet]. [cited 2018 May 29]. Available from: http://www.cardioinfantil.org/index.php/conoce-la-fundacion Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J Clin Res Ed. 1986 Mar 15;292(6522):746–50 Saavedra CH, Ordóñez KM, Díaz JA. Impacto de la infección nosocomial en un hospital de Bogotá (Colombia): efectos en mortalidad y costos. Rev Chil Infectol. 2015 Feb;32(1):25–9 Saltman AP, Silver FL, Fang J, Stamplecoski M, Kapral MK. Care and Outcomes of Patients With In-Hospital Stroke. JAMA Neurol. 2015 Jul;72(7):749–55 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
1. Pope HJ, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163-70. 2. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82. 3. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2007. CDC WONDER Database, compiled from Compressed Mortality File 1999-2007 Series 20 No. 2K, 2008. Accessed on: http://wonder.cdc.gov/cmf-icd10.html on Feb 20, 2011. 4. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;98:2334-51. 5. Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000;21:1406-32. 6. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. 7. Anderson JL, Adams CD, Antman EM, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116:e148. 8. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82. 9. Blomkalns AL, Gibler WB: Chest pain unit concept: rationale and diagnostic strategies. Cardiol Clin 2005; 23:411. 11. Morrow DA, Cannon CP, Jesse RL, et al: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115:e356. 12. Wu AH, Jaffe AS, Apple FS, et al: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53:2086. 13. Keller T, Zeller T, Peetz D, et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 61:868. 14. Puleo PR, Meyer D, Watchen C, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose to rule out acute myocardial infarctation. N Engl J Med 1994;331:561-66. 15. Fesmire FM, Christenson RH, Fody EP, et al. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 2004;44:12-9. 16. Ghani F, Wu AH, Graff L, et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000;46:718-9. 17. Ruzgar O, Bilge AK et al. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase–myocardial band. Heart Vessels 2006;21:309–14. 18. Bhagavan NV, Ha JS, Park JH, et al. Utility of serum Fatty Acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem. 2009;55:1588-90. 19. Seino Y, Ogata K, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003;115:185-90. 20. Bruins Slot MH, van der Heijden GJ, Rutten FH, et al. Heart-type Fatty acid-binding protein in Acute Myocardial infarction Evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord 2008;8:8-13 21. Tong CY, Chan CP, Cheung KY et al. A point-of-care immunotest for bedside determination of heart-type fatty acid-binding protein. Analytical Letters 2010;43:735-44. 22. Kabekkodu S, Mananje S, Saya R. A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction. Journal of Clinical and Diagnostic Research 2016;10: 7 – 10. 23. Pyati A, Devaranavadagi B, Sajjannar S, et al. Heart Type Fatty Acid Binding Protein: A better cardiac biomarker than CK – MB and myoglobin in the early diagnosis of acute myocardial infarction. Journal of Clinical and Diagnostic Research 2015;9: 8 – 11. 24. Reiter M, Twerenbold R, Reichlin T, et al. Heart type fatty acid binding protein in the early diagnosis of acute myocardial infarction. Heart 2013;99:708-714. 25. Schoenenberger A, Stallone F, Walz B, et al. Incremental value of heart type fatty acid binding protein in suspected acute myocardial infarction early after symptoms onset. Eur Heart J Acute Cardiovasc Care 2016;5(2):185-92. 26. Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Am Transl Med 2016;4(10): 1 – 11. 27. Ladue JS, Wröblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction. Science 1954; 120:497 – 9. 28. Ulmer DD, Valle BL, Wacker WE. Metalloenzymes and myocardial infarction. Malic an lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med 1956;255:450 – 6. 29. Dreyfus JC, Schapira G, Rasnais J, et al. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol 1960;5: 386-7. 30. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high sensitivity cardiac troponin T assay. Clin Chem 2010;56:254 – 61. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Biomédica, Volume: 36, Issue: 2, Pages: 276-284, Published: JUN 2016 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Lai HM, Pawar R, Wolf DC, Aronow WS. Impact of Cardiovascular Risk Factors on Long-Term Mortality After Liver Transplantation. Am J Ther. 2014 Jun Marchetti P. New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. United States; 2005 Jun;11(6):612–20. Kuo H-T, Sampaio MS, Ye X, Reddy P, Martin P, Bunnapradist S. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. United States; 2010 May;89(9):1134–40. Simo KA, Sereika S, Bitner N, Newton KN, Gerber DA. Medical epidemiology of patients surviving ten years after liver transplantation. Clin Transplant. Denmark; 2011;25(3):360–7. Bodziak K a, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int. 2009 May;22(5):519–30. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant. Denmark; 2005 Jun;19(3):291–8. Ye X, Kuo H-T, Sampaio MS, Jiang Y, Reddy P, Bunnapradist S. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Transplantation. United States; 2010 Jun;89(12):1526–32. Castro D. Diabetes en pacientes que reciben trasplante de organos. Universidad del Rosario; 2010. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation. United States; 2006 Dec;82(12):1625–8. Mejia G, Varon A. POSTER: “Transplante hepático en adultos: experiencia en la Fundación Cardioinfantil.” Bogotá, Colombia; 2012. Oufroukhi L, Kamar N, Muscari F, Lavayssiere L, Guitard J, Ribes D, et al. Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation. United States; 2008 May;85(10):1436–42. Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc. United States; 2005;37(6):2636–7. Saliba F, Lakehal M, Pageaux G-P, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. United States; 2007 Jan;13(1):136–44. Chen T, Jia H, Li J, Chen X, Zhou H, Tian H. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies. Transpl Int. Germany; 2009 Apr;22(4):408–15. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med. England; 2012 Jul;29(7):e1–12. Pageaux G-P, Faure S, Bouyabrine H, Bismuth M, Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. United States; 2009 Nov;15 Suppl 2:S79–82. Van Laecke S, Desideri F, Geerts A, Van Vlierberghe H, Berrevoet F, Rogiers X, et al. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. United States; 2010 Nov;16(11):1278–87. Veldt BJ, Duarte-Rojo A, Thompson AJ, Watt KD, Heimbach JK, Tillmann HL, et al. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. Am J Transplant. United States; 2012 Mar;12(3):737–44. Care M. Standards of medical care in diabetes--2013. Diabetes Care. 2013;36 Suppl 1:S11–66. Xu X, Ling Q, He Z-L, Gao F, Zheng S-S. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int. China; 2008 Oct;7(5):465–70. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario